Kronox Lab Sciences Board of Directors

Get the latest insights into the leadership at Kronox Lab Sciences. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Jogindersingh Jaswal Chairman & Managing Director
Mr. Pritesh Ramani Whole Time Director
Mr. Ketan Ramani Whole Time Director
Ms. Krutika Negandhi Independent Director
Mr. Satish Kumar Independent Director
Mr. Parth Shah Independent Director

Kronox Lab Sciences Share price

KRONOX

165.77

2.08 (-1.24%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High

168.96

Today's Low

165.10

52 Week Low

132.05

52 Week High

228.88

The current prices are delayed, login to your account for live prices

Kronox Lab Sciences FAQs

The board at Kronox Lab Sciences consists of experienced professionals, including Mr. Jogindersingh Jaswal , Mr. Pritesh Ramani , and others, overseeing the company’s strategic and corporate governance.

Directors at Kronox Lab Sciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Jogindersingh Jaswal is the current chairman at Kronox Lab Sciences.

Executive directors at Kronox Lab Sciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Kronox Lab Sciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Kronox Lab Sciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.